Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Adler, I.-D.
Right arrow Articles by Speicher, M.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adler, I.-D.
Right arrow Articles by Speicher, M.R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis, Vol. 17, No. 5, 383-389, September 2002
© 2002 UK Environmental Mutagen Society/Oxford University Press

Induction of chromosomal aberrations by dacarbazine in somatic and germinal cells of mice

I.-D. Adler1,4, U. Kliesch1, I. Jentsch2,3 and M.R. Speicher2,3

1 Institut für Experimentelle Genetik and 2 Institut für Humangenetik, GSF-Forschungszentrum für Umwelt und Gesundheit, Ingolstaedter Landstrasse 1, D-85764 Neuherberg, Germany and 3 Institut für Humangenetik, Technische Universität München, D-81675 München, Germany

Dacarbazine (DTIC) is a chemotherapeutic agent that has been successfully applied to treat various types of cancer such as Hodgkin’s disease, malignant melanomas, soft tissue sarcomas and advanced neuroblastomas. Many of the patients are of reproductive age and express concern over the genetic risk of the treatment they receive. Therefore, DTIC was tested for its clastogenic effects in somatic and germinal cells of mice. In the bone marrow micronucleus assay DTIC induced micronuclei that increased linearly in the dose range 0–125 mg/kg. In a dominant lethal study DTIC gave a positive response at the dose of 500 mg/kg when conceptions occurred 5–16 days after treatment, corresponding to treated spermatids and early spermatozoa. The induction of heritable translocations was tested in that sensitive period. The observed translocation rate among the F1 progeny of male mice treated with 500 mg/kg DTIC was 2.13% (P < 00.1 against the historical control of 0.05%). Assuming linearity of the dose–response effect, the point estimate was used to calculate a doubling dose for the induction of heritable translocations of 12 mg/kg. Alternatively, an induced translocation rate of 41.6x10–6 per unit dose was calculated. Both figures indicate that an increased genetic risk may exist for male patients after chemotherapy with DTIC under the assumption that germ cells of mice and humans are equally sensitive to the clastogenic effects of DTIC. However, the genetic risk is restricted to conceptions within a period of 40 days after the end of chemotherapy, since the sensitive stages of spermatogenesis are spermatids and early spermatozoa.

4 To whom correspondence should be addressed. Tel: 49 89 3187 2302; Fax: 49 89 3187 2210; Email: adler{at}gsf.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
L. Froenicke, P.-H. Hung, C. A. VandeVoort, and L. A. Lyons
Development of a non-human primate sperm aneuploidy assay tested in the rhesus macaque (Macaca mulatta)
Mol. Hum. Reprod., July 1, 2007; 13(7): 455 - 460.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
C. Maierhofer, I. Jentsch, G. Lederer, C. Fauth, and M. R.Speicher
Multicolor FISH in two and three dimensions for clastogenic analyses
Mutagenesis, November 1, 2002; 17(6): 523 - 527.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.